Primary central nervous system lymphoma imaged with FDG-PET/CT

被引:0
|
作者
Marti Samper, Alejandro [1 ]
机构
[1] Inst Nacl Cancerol, Grp Med Nucl PET, Bogota, Colombia
来源
REVISTA COLOMBIANA DE CANCEROLOGIA | 2013年 / 17卷 / 03期
关键词
Positron emission tomography; Primary central nervous system lymphoma; Staging;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Primary central nervous system lymphoma (PCNSL) is now known as a form of non-Hodgkin extranodal high-grade B-cell, usually diffuse large B cell, originating in the brain, leptomeninges, spinal cord or eyes, and usually remains confined to the central nervous system (CNS). The main risk factor is immunodeficiency. It represents 4% of primary CNS tumors, with an incidence rate adjusted for age of 4/1,000,000/year. Positron emission tomography (PET) has shown to have an impact on staging impact patients with diffuse large B cell lymphoma, but there is limited experience in cases of primary CNS involvement. (C) 2013 Instituto Nacional de Cancerologia. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:126 / 129
页数:4
相关论文
共 50 条
  • [31] Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
    Park J.S.
    Yim J.-J.
    Kang W.J.
    Chung J.-K.
    Yoo C.-G.
    Kim Y.W.
    Han S.K.
    Shim Y.-S.
    Lee S.-M.
    BMC Research Notes, 4 (1)
  • [32] Utility of FDG-PET in primary renal lymphoma
    Bahure, Sarita
    Cheung, Joshua Chun Yin
    Lin, Michael
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (01) : 158 - 159
  • [33] The diagnostic role of 18F-FDG PET for primary central nervous system lymphoma
    Yamaguchi, Shigeru
    Hirata, Kenji
    Kobayashi, Hiroyuki
    Shiga, Tohru
    Manabe, Osamu
    Kobayashi, Kentaro
    Motegi, Hiroaki
    Terasaka, Shunsuke
    Houkin, Kiyohiro
    ANNALS OF NUCLEAR MEDICINE, 2014, 28 (07) : 603 - 609
  • [34] The diagnostic role of 18F-FDG PET for primary central nervous system lymphoma
    Shigeru Yamaguchi
    Kenji Hirata
    Hiroyuki Kobayashi
    Tohru Shiga
    Osamu Manabe
    Kentaro Kobayashi
    Hiroaki Motegi
    Shunsuke Terasaka
    Kiyohiro Houkin
    Annals of Nuclear Medicine, 2014, 28 : 603 - 609
  • [35] Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric study
    Rozenblum, Laura
    Houillier, Caroline
    Baptiste, Amandine
    Soussain, Carole
    Edeline, Veronique
    Naggara, Philippe
    Soret, Marine
    Causse-Lemercier, Valerie
    Willems, Lise
    Choquet, Sylvain
    Ursu, Renata
    Galanaud, Damien
    Belin, Lisa
    Hoang-Xuan, Khe
    Kas, Aurelie
    NEURO-ONCOLOGY, 2024, 26 (07) : 1292 - 1301
  • [36] Utility of FDG-PET in primary renal lymphoma
    Sarita Bahure
    Joshua Chun Yin Cheung
    Michael Lin
    Clinical and Experimental Nephrology, 2015, 19 : 158 - 159
  • [37] 18F-FDG PET in the Diagnosis and Treatment of Primary Central Nervous System Lymphoma
    Kawai, Nobuyuki
    Miyake, Keisuke
    Yamamoto, Yuka
    Nishiyama, Yoshihiro
    Tamiya, Takashi
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [38] Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma
    Karantanis, Dimitrios
    ONeill, Brian P.
    Subramaniam, Rathan M.
    Peller, Patrick J.
    Witte, Robert J.
    Mullan, Brian P.
    Wiseman, Gregory A.
    CLINICAL NUCLEAR MEDICINE, 2007, 32 (04) : 271 - 274
  • [39] Primary Central Nervous System Lymphoma Revealed by 68Ga-FAPI and 18F-FDG PET/CT
    Zhang, Ying
    Cai, Jiawei
    Lin, Zefang
    Yao, Shaobo
    Miao, Weibing
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (08) : E421 - E423
  • [40] Enhanced MRI and 18F-FDG PET/CT Findings of Primary Central Nervous System Lymphoma Mimicking Encephalitis
    Ge, Jingjie
    Zuo, Chuantao
    Guan, Yihui
    Zhao, Guixian
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (10) : e436 - e438